APA (7th ed.) Citation

M, K., M, Z., JD, C., & S, D. (2019). Exposure-response analysis of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy. British journal of clinical pharmacology, 85(4), 807. https://doi.org/10.1111/bcp.13864

Chicago Style (17th ed.) Citation

M, Kuchimanchi, Zhu M, Clements JD, and Doshi S. "Exposure-response Analysis of Blinatumomab in Patients with Relapsed/refractory Acute Lymphoblastic Leukaemia and Comparison with Standard of Care Chemotherapy." British Journal of Clinical Pharmacology 85, no. 4 (2019): 807. https://doi.org/10.1111/bcp.13864.

MLA (9th ed.) Citation

M, Kuchimanchi, et al. "Exposure-response Analysis of Blinatumomab in Patients with Relapsed/refractory Acute Lymphoblastic Leukaemia and Comparison with Standard of Care Chemotherapy." British Journal of Clinical Pharmacology, vol. 85, no. 4, 2019, p. 807, https://doi.org/10.1111/bcp.13864.